The Bacterial Symbiont Wolbachia Induces Resistance to RNA Viral Infections in Drosophila melanogaster

A Drosophila lab, sometime in the mid-2000s. Flies are in glass vials, each one injected with a dose of Drosophila C virus, which is a naturally occurring RNA pathogen that kills fruit flies reliably and quickly. In most vials, the flies are dead within twelve days. But in some vials, a large fraction of the flies are still alive at day twenty-one. And here's the thing: those survivors look genetically identical to the dead ones. They have the same background strain, the same insertion line designation, and the same virus dose. Something invisible is protecting them. That was the puzzle Luís Teixeira, Álvaro Ferreira, and Michael Ashburner found themselves staring at. They had set up a genetic screen, the type where you systematically test thousands of fly lines carrying P-element insertions, which are small genetic tags, hoping to find mutations that make flies extra sensitive to the virus. Instead, they got the opposite: some lines that were unexpectedly resistant. When they checked whether the P-element itself was causing the protection, it wasn't. The resistance tracked the mother, not the mutation. Progeny from resistant mothers were resistant. Progeny from sensitive mothers were not. Mixing them together didn't change anything. The next clue came from an antibiotic. When the team raised resistant flies on food containing tetracycline, the protection disappeared. Those flies died just like the sensitive controls. Staining embryos from resistant lines revealed extranuclear DNA—bacterial signal, living inside the egg cells, passed directly from mother to offspring. Something tetracycline sensitive, intracellular, and maternally transmitted was keeping these flies alive. That combination points in exactly one direction: Wolbachia. Wolbachia are obligatory intracellular bacteria, specifically alpha-proteobacteria that live inside arthropod cells and are transmitted almost exclusively through the female germline. They are spectacularly common. Estimates place them in somewhere between seventeen and seventy-six percent of surveyed arthropod species, with one recent estimate suggesting they infect about sixty-six percent of all arthropod species. That makes Wolbachia one of the most successful endosymbionts on the planet. They were discovered in Culex mosquitoes in nineteen twenty-four, and for most of their scientific history, they have been known as reproductive manipulators. Cytoplasmic incompatibility, which is the most famous trick, means that infected males can't successfully reproduce with uninfected females. This gives infected females a numbers advantage in the next generation and spreads the bacterium through populations quickly. Other strains kill males outright, convert them into females, or allow females to reproduce without males at all. These are the strategies of a reproductive parasite: Wolbachia spreads by tilting the sex ratio in its own favor. But in some hosts, Wolbachia are genuinely essential. In the parasitic wasp Asobara tabida, Wolbachia prevents programmed cell death in the female germline. Without it, the wasp can't produce eggs. In filarial nematodes, which are the parasites that cause river blindness and elephantiasis, Wolbachia are required for normal development. So, the relationship runs from parasite to obligate mutualist depending on the host. What it had never done, at least not demonstrably, was provide a clear benefit in Drosophila melanogaster. The common wMel strain infecting lab flies induced only a weak cytoplasmic incompatibility effect. There was no strong phenotype. This made what Teixeira and colleagues found all the more striking. To nail down causality, they built the cleanest possible experiment. They took resistant fly lines carrying Wolbachia and cured them with tetracycline, producing otherwise genetically identical flies that differed only in whether Wolbachia was present. Then they infected both groups with Drosophila C virus, which is a small non-enveloped RNA virus in the Dicistroviridae family, and measured who died and how much virus accumulated. The results were dramatic. At a challenge dose of five hundred times the median tissue culture infective dose, which is a standard lethal challenge, all Wolbachia-free males died within twelve days. Flies carrying Wolbachia showed much lower mortality through day twenty-one. More telling was the viral load: three days after infection, Drosophila C virus titer in Wolbachia-free flies was ten thousand times higher than in Wolbachia-carrying flies. Western blots showed Drosophila C virus proteins undetectable in Wolbachia-infected flies but clearly present and rising in cured flies. The statistical tests were tight: Mann-Whitney p-values of zero point zero three for the titer comparisons, and a combined Fisher's exact p-value of zero point zero zero zero six across six independent wild-type lines. Molecular confirmation came from polymerase chain reaction using Wolbachia-specific primers and sequencing of sixteen S ribosomal RNA amplicons that came back at least ninety-nine point five percent identical to a known Wolbachia sequence. The logic here is airtight. Same genetic background. Same virus dose. One variable changed. Wolbachia in, flies live and carry almost no virus. Wolbachia out, flies die and carry ten thousand times as much. The team then asked how far this effect extended. They tested two more RNA viruses and one DNA virus. Nora virus is a naturally occurring Drosophila pathogen—small, non-enveloped, single-stranded RNA, similar to picornaviruses, spread through contaminated food. Flock House virus, which is abbreviated as FHV, is a nodavirus with two positive-sense RNA segments, well characterized in the lab, and lethal when injected. Insect Iridescent Virus 6, which is abbreviated as IIV-6, is a large double-stranded DNA virus from the Iridoviridae, which is a completely different kind of pathogen. Wolbachia protected against both RNA viruses. For Nora virus, semi-quantitative reverse transcription polymerase chain reaction consistently showed lower viral levels in Wolbachia-infected flies across four independent experiments. For Flock House virus, the survival difference was stark: all Wolbachia-free flies were dead by day thirteen after injection with fifty infectious units. Only forty percent of Wolbachia-carrying flies had died by day twenty-one. That's a massive survival advantage. Insect Iridescent Virus 6 was different. Against that DNA virus, Wolbachia offered no protection at all. Wolbachia-infected flies actually died slightly faster, and IIV-6 titers at day ten reached roughly one billion infectious units per fly in both groups, with no meaningful difference. The pattern that emerged was clean: RNA viruses yes, DNA virus no. That specificity starts to tell you something about the mechanism, even if the mechanism itself remains unresolved. Teixeira and colleagues lay out several non-exclusive possibilities. One is resource competition: Wolbachia live in the cytoplasm and depend heavily on host amino acid metabolism, and Drosophila C virus is extremely sensitive to perturbations in host translation. Maybe Wolbachia depletes the cytoplasmic resources RNA viruses need to replicate. Another possibility is direct interference: Wolbachia encodes a type four secretion system and numerous ankyrin-repeat proteins, which are molecular tools that could deliver effectors directly into the host cell environment to block viral processes. A third hypothesis involves the host's own immune system. Wolbachia might prime innate immunity, preactivating antiviral pathways so the fly responds faster and harder when a virus arrives. The RNA interference pathway, which is the primary antiviral defense in insects, is one candidate. But the paper is careful here: Wolbachia doesn't consistently activate antimicrobial peptide expression in other Drosophila species or in Aedes mosquitoes, so a simple blanket immune activation isn't the whole story. There's also a subtler possibility suggested by the Flock House virus data specifically. The survival benefit against Flock House virus was large, but the difference in viral titer between infected and uninfected flies was only about one point eight-fold and not statistically significant. That gap—big survival difference, small titer difference—suggests Wolbachia might partly be protecting flies from the damage viruses cause, not just from viral replication itself. The bacterium is known to inhibit apoptosis, which is programmed cell death, in other contexts. Flock House virus triggers apoptosis in cultured cells. Those two facts fit together suggestively, even if they haven't been directly connected yet. The authors are honest that these are open questions. The phenomenon is real and reproducible. The mechanism is not pinned down. What is clear is the ecological implication. If Wolbachia protects Drosophila from naturally circulating RNA viruses—Drosophila C virus and Nora virus are both found in wild fly populations—then carrying Wolbachia is a genuine fitness advantage in the wild. That advantage could explain something that had been puzzling: why Wolbachia is so prevalent in natural Drosophila populations despite inducing only a weak reproductive manipulation effect in this host. A bacterium that cuts your viral load by ten thousand-fold doesn't need to manipulate reproduction to spread. Survival is enough. And the implications extend well beyond fruit flies. Wolbachia infects an enormous fraction of arthropod species, including mosquitoes that transmit RNA viruses to humans. Teixeira and colleagues note this directly. The possibility that introducing Wolbachia into disease-carrying vectors could reduce virus transmission was already attracting interest when this paper was published in two thousand eight. That idea has since been tested in the field. But the conceptual foundation was laid right here, in fly vials with unexplained survivors. The deeper point is this: a host's resistance to a pathogen is not just a property of the host. It depends on who else is living inside. This lecture was created by ennepō. Go to https://ennepo.ai to Discover, Create and Follow the latest research in your field. Read when you can. Listen when you want to.